Abou-Sleiman, Patrick M., Miratul M. K. Muqit, and Nicholas W. Wood, ‘Expanding Insights of Mitochondrial Dysfunction in Parkinson’s Disease’, Nature Reviews Neuroscience, 7.3 (2006), 207–19 <https://doi.org/10.1038/nrn1868>
Altshuler, D., M. J. Daly, and E. S. Lander, ‘Genetic Mapping in Human Disease’, Science, 322.5903 (2008), 881–88 <https://doi.org/10.1126/science.1156409>
Antonarakis, Stylianos E., and Jacques S. Beckmann, ‘Mendelian Disorders Deserve More Attention’, Nature Reviews Genetics, 7.4 (2006), 277–82 <https://doi.org/10.1038/nrg1826>
‘Atherosclerosis — An Inflammatory Disease — NEJM’
Balding, David J., ‘A Tutorial on Statistical Methods for Population Association Studies’, Nature Reviews Genetics, 7.10 (2006), 781–91 <https://doi.org/10.1038/nrg1916>
Bishop, M., Cannings, C., and Balding, D. J., Handbook of Statistical Genetics, 3rd ed (Chichester: John Wiley, 2007) <https://onlinelibrary.wiley.com/doi/book/10.1002/9781119487845>
Botstein, David, and Neil Risch, ‘Discovering Genotypes Underlying Human Phenotypes: Past Successes for Mendelian Disease, Future Approaches for Complex Disease’, Nature Genetics, 33.3s (2003), 228–37 <https://doi.org/10.1038/ng1090>
Bras, Jose Miguel, and Andrew Singleton, ‘Genetic Susceptibility in Parkinson’s Disease’, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1792.7 (2009), 597–603 <https://doi.org/10.1016/j.bbadis.2008.11.008>
Brinkman, Ryan R., Marie-Pierre Dubé, Guy A. Rouleau, Andrew C. Orr, and Mark E. Samuels, ‘Human Monogenic Disorders — a Source of Novel Drug Targets’, Nature Reviews Genetics, 7.4 (2006), 249–60 <https://doi.org/10.1038/nrg1828>
Burton, Paul, Palmer, Lyle, and Smith, George Davey, An Introduction to Genetic Epidemiology (Bristol: Policy Press, 2011), Health&society series
Capecchi, Mario R., ‘Essay: Gene Targeting in Mice: Functional Analysis of the Mammalian Genome for the Twenty-First Century’, Nature Reviews Genetics, 6.6 (2005), 507–12 <https://doi.org/10.1038/nrg1619>
Daly, Ann K., ‘Genome-Wide Association Studies in Pharmacogenomics’, Nature Reviews Genetics, 11.4 (2010), 241–46 <https://doi.org/10.1038/nrg2751>
Foulkes, Andrea S., Applied Statistical Genetics with R: For Population-Based Association Studies (Dordrecht: Springer, 2009), Use R! <https://doi.org/10.1007/978-0-387-89554-3>
Gibb, Alasdair J., Foreman, John C., and Johansen, Torben, Textbook of Receptor Pharmacology, 3rd ed (Boca Raton, FL: CRC Press, 2011) <https://doi.org/10.1201/9781420052558>
Hall, Ian P., and Munir Pirmohamed, Pharmacogenetics (New York: Taylor & Francis, 2006) <https://doi.org/10.3109/9781420016697>
Hansson, Göran K., and Peter Libby, ‘The Immune Response in Atherosclerosis: A Double-Edged Sword’, Nature Reviews Immunology, 6.7 (2006), 508–19 <https://doi.org/10.1038/nri1882>
Hirschhorn, Joel N., and Mark J. Daly, ‘Genome-Wide Association Studies for Common Diseases and Complex Traits’, Nature Reviews Genetics, 6.2 (2005), 95–108 <https://doi.org/10.1038/nrg1521>
Holmes, Michael V., ‘CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular EventsA Systematic Review and Meta-Analysis’, JAMA: The Journal of the American Medical Association, 306.24 (2011) <https://doi.org/10.1001/jama.2011.1880>
Holmes, Michael V., Tina Shah, Christine Vickery, Liam Smeeth, Aroon D. Hingorani, and Juan P. Casas, ‘Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies’, PLoS ONE, 4.12 (2009) <https://doi.org/10.1371/journal.pone.0007960>
———, ‘Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies’, PLoS ONE, 4.12 (2009) <https://doi.org/10.1371/journal.pone.0007960>
Humphries, Steve E., and Aroon Hingorani, ‘Pharmacogenetics: Progress, Pitfalls and Clinical Potential for Coronary Heart Disease’, Vascular Pharmacology, 44.2 (2006), 119–25 <https://doi.org/10.1016/j.vph.2005.10.003>
Kathiresan, Sekar, Benjamin F Voight, Shaun Purcell, Kiran Musunuru, Diego Ardissino, Pier M Mannucci, and others, ‘Genome-Wide Association of Early-Onset Myocardial Infarction with Single Nucleotide Polymorphisms and Copy Number Variants’, Nature Genetics, 41.3 (2009), 334–41 <https://doi.org/10.1038/ng.327>
Kenakin, Terrence P., A Pharmacology Primer: Theory, Applications, and Methods, 3rd ed (Burlington, MA: Elsevier Academic Press, 2009) <https://www-sciencedirect-com.libproxy.ucl.ac.uk/book/9780123745859/a-pharmacology-primer>
Kirkwood, Betty R., Kirkwood, Betty R., and Sterne, Jonathan A. C., Essential Medical Statistics, 2nd ed (Malden, Mass: Blackwell Science, 2003)
Lee, Alvin J.X., and Charles Swanton, ‘Tumour Heterogeneity and Drug Resistance: Personalising Cancer Medicine through Functional Genomics’, Biochemical Pharmacology, 83.8 (2012), 1013–20 <https://doi.org/10.1016/j.bcp.2011.12.008>
Lefkowitz, Robert J., ‘Historical Review: A Brief History and Personal Retrospective of Seven-Transmembrane Receptors’, Trends in Pharmacological Sciences, 25.8 (2004), 413–22 <https://doi.org/10.1016/j.tips.2004.06.006>
Lesk, Arthur M., Introduction to Bioinformatics, 3rd ed (Oxford: Oxford University Press, 2008)
McCarthy, Mark I., Gonçalo R. Abecasis, Lon R. Cardon, David B. Goldstein, Julian Little, John P. A. Ioannidis, and others, ‘Genome-Wide Association Studies for Complex Traits: Consensus, Uncertainty and Challenges’, Nature Reviews Genetics, 9.5 (2008), 356–69 <https://doi.org/10.1038/nrg2344>
Neale, Benjamin M. and International Workshop of Twin and Family Studies, Statistical Genetics: Gene Mapping through Linkage and Association (Abingdon: Taylor & Francis, 2008)
Neubig, R. R., ‘International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology’, Pharmacological Reviews, 55.4 (2003), 597–606 <https://doi.org/10.1124/pr.55.4.4>
‘New Perspectives for the Elucidation of Genetic Disorders’ <https://doi.org/520679>
O’Connor, Timothy P., and Ronald G. Crystal, ‘Genetic Medicines: Treatment Strategies for Hereditary Disorders’, Nature Reviews Genetics, 7.4 (2006), 261–76 <https://doi.org/10.1038/nrg1829>
Orengo, Christine Ann, Jones, David Tudor, and Thornton, Janet M., Bioinformatics: Genes, Proteins and Computers (Oxford: BIOS, 2003) <https://www.vlebooks.com/Product/Index/2052147?page=0&startBookmarkId=-1>
Ropers, Hans-Hilger, ‘New Perspectives for the Elucidation of Genetic Disorders’, The American Journal of Human Genetics, 81.2 (2007), 199–207 <https://doi.org/10.1086/520679>
Seifert, Roland, and Katharina Wenzel-Seifert, ‘Constitutive Activity of G-Protein-Coupled Receptors: Cause of Disease and Common Property of Wild-Type Receptors’, Naunyn-Schmiedeberg’s Archives of Pharmacology, 366.5 (2002), 381–416 <https://doi.org/10.1007/s00210-002-0588-0>
Sham, P., Statistics in Human Genetics (Chichester: Wiley, 2007)
‘Table of Contents : Nature Reviews Genetics Focus on Monogenic Disorders’
Thomas, Duncan C., Statistical Methods in Genetic Epidemiology (New York: Oxford University Press, 2004)
Thompson, Andrew J., Henry A. Lester, and Sarah C. R. Lummis, ‘The Structural Basis of Function in Cys-Loop Receptors’, Quarterly Reviews of Biophysics, 43.04 (2010), 449–99 <https://doi.org/10.1017/S0033583510000168>
Yusuf, Salim, Steven Hawken, Stephanie Ôunpuu, Tony Dans, Alvaro Avezum, Fernando Lanas, and others, ‘Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART Study): Case-Control Study’, The Lancet, 364.9438 (2004), 937–52 <https://doi.org/10.1016/S0140-6736(04)17018-9>
Zvelebil, Marketa J. and Baum, Jeremy O., Understanding Bioinformatics (New York: Garland Science, 2008) <https://bibliu.com/app/#/view/books/9781136976964/pdf2htmlex/index.html#page_Cover>
